«Cancer is like a person's thumbprint; each person's cancer is uniquely theirs,» says Bill Hearl, CEO of Immunomic Therapeutics, a clinical stage biotechnology company developing a nucleic acid immunotherapy platform with the potential to treat cancer, allergies and animal health issues. (scientificamerican.com)
• Myonexus Therapeutics, a New Albany, Oh. - based clinical - stage biotechnology company developing transformative gene therapies for limb - girdle muscular dystrophies, raised $ 2.5 million in seed funding. (fortune.com)
Dr. Michael West: The CEO of BioTime, Inc., a leading clinical - stage biotechnology company in the field of regenerative medicine. (mauldineconomics.com)